Histopathological effects of Algan hemostatic agent (AHA) in liver injury model in rats

Basit Öğe Kaydı
dc.authoridSener Akcora, Dila/0000-0001-9496-7324
dc.authoridKocak, Mihrican/0000-0003-0106-6602
dc.authoridDeveci, Ugur/0000-0003-4449-1190
dc.contributor.authorSener, Dila
dc.contributor.authorKocak, Mihrican
dc.contributor.authorSaracoglu, Ramazan
dc.contributor.authorDeveci, Ugur
dc.contributor.authorKaradag, Mehmet
dc.date.accessioned2024-09-18T19:52:34Z
dc.date.available2024-09-18T19:52:34Z
dc.date.issued2022
dc.departmentHatay Mustafa Kemal Üniversitesien_US
dc.description.abstractBackground and Aim: In this study, we aimed to assess the hemostatic and histopathological impacts of the Algan hemostatic agent (AHA) with the liver injury model. Materials and Methods: 24 male rats, 10-12 week old, were randomly divided into three equal groups (n=8) as control (physiological saline solution), AHA liquid and AHA powder. A total of three iatrogenic cut injuries were performed on the anterior surface of the left liver lobe. After bleeding started, sponges soaked with physiological saline, AHA liquid, AHA powder were gently pressed on the injured area for 20 seconds in corresponding groups, respectively. The bleeding time was measured with a timer. Failure to stop bleeding after three consecutive applications was considered as a failure. Animals were euthanized at the tenth minute of the procedure. Left liver lobes were removed for histopathological examination. Results: Bleeding control success rates of AHA liquid were significantly higher than that of the AHA powder group, and both forms were more effective than physiological saline. A superficial thick granulation tissue with entrapped powder residual materials was detected in the AHA powder group. Liver parenchyma was intact in liquid and powder groups. Conclusion: AHA is a fast-acting and applicable hemostatic agent in the liver bleeding model. However, further comparative studies in various organs are needed.en_US
dc.identifier.doi10.14744/hf.2021.2021.0040
dc.identifier.endpage20en_US
dc.identifier.issn1307-5888
dc.identifier.issn2757-7392
dc.identifier.issue1en_US
dc.identifier.pmid35782368en_US
dc.identifier.scopus2-s2.0-85164368002en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage16en_US
dc.identifier.trdizinid1170037en_US
dc.identifier.urihttps://doi.org/10.14744/hf.2021.2021.0040
dc.identifier.urihttps://search.trdizin.gov.tr/tr/yayin/detay/1170037
dc.identifier.urihttps://hdl.handle.net/20.500.12483/7526
dc.identifier.volume3en_US
dc.identifier.wosWOS:000863555800004en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakTR-Dizinen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherKare Publen_US
dc.relation.ispartofHepatology Forumen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectAlgan hemostatic agenten_US
dc.subjectinjuryen_US
dc.subjecttraumaen_US
dc.subjectliveren_US
dc.subjectraten_US
dc.titleHistopathological effects of Algan hemostatic agent (AHA) in liver injury model in ratsen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
7526.pdf
Boyut:
1.18 MB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
İndir

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu
TR-Dizin İndeksli Yayınlar Koleksiyonu